{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T03:33:10Z","timestamp":1780716790855,"version":"3.54.1"},"reference-count":20,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Emergency Medicine"],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.1016\/j.annemergmed.2011.10.015","type":"journal-article","created":{"date-parts":[[2011,12,8]],"date-time":"2011-12-08T18:26:07Z","timestamp":1323368767000},"page":"307-317.e1","source":"Crossref","is-referenced-by-count":24,"title":["Pharmacologic Prophylaxis for Acute Mountain Sickness: A Systematic Shortcut Review"],"prefix":"10.1016","volume":"59","author":[{"given":"Rawle A.","family":"Seupaul","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie L.","family":"Welch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah T.","family":"Malka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas W.","family":"Emmett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.annemergmed.2011.10.015_bib1","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1136\/bmj.321.7256.267","article-title":"Efficacy and harm of pharmacological prevention of acute mountain sickness: quantitative systematic review","volume":"321","author":"Dumont","year":"2000","journal-title":"BMJ"},{"key":"10.1016\/j.annemergmed.2011.10.015_bib2","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1056\/NEJM200107123450206","article-title":"High-altitude illness","volume":"345","author":"Hackett","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.annemergmed.2011.10.015_bib3","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/S0140-6736(76)91677-9","article-title":"The incidence, importance, and prophylaxis of acute mountain sickness","volume":"2","author":"Hackett","year":"1976","journal-title":"Lancet"},{"key":"10.1016\/j.annemergmed.2011.10.015_bib4","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1056\/NEJM200107123450206","article-title":"High-altitude illness","volume":"345","author":"Hackett","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.annemergmed.2011.10.015_bib6","series-title":"Cochrane Handbook for Systematic Reviews of Interventions [updated September 2009]","year":"2009"},{"key":"10.1016\/j.annemergmed.2011.10.015_bib7","first-page":"41","article-title":"Developing optimal search strategies for detecting clinically sound treatment studies in EMBASE","volume":"94","author":"Wong","year":"2006","journal-title":"J Med Libr Assoc"},{"key":"10.1016\/j.annemergmed.2011.10.015_bib8","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1580\/1080-6032-17.2.87","article-title":"Prevention of acute mountain sickness by acetazolamide in Nepali porters: a double-blind controlled trial","volume":"17","author":"Hillenbrand","year":"2006","journal-title":"Wilderness Environ Med"},{"key":"10.1016\/j.annemergmed.2011.10.015_bib9","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1089\/152702903321488979","article-title":"Efficacy of low-dose acetazolamide (125 mg BID) for the prophylaxis of acute mountain sickness: a prospective, double-blind, randomized, placebo-controlled trial","volume":"4","author":"Basnyat","year":"2003","journal-title":"High Alt Med Biol"},{"key":"10.1016\/j.annemergmed.2011.10.015_bib10","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1042\/CS20030187","article-title":"Magnesium for the prevention and treatment of acute mountain sickness","volume":"106","author":"Dumont","year":"2004","journal-title":"Clin Sci"},{"key":"10.1016\/j.annemergmed.2011.10.015_bib11","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1046\/j.1365-2265.2002.01664.x","article-title":"Glucocorticoids as prophylaxis against acute mountain sickness","volume":"57","author":"Basu","year":"2002","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.annemergmed.2011.10.015_bib12","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.wem.2010.06.009","article-title":"Prospective, double-blind, randomized, placebo-controlled comparison of acetazolamide versus ibuprofen for prophylaxis against high altitude headache: the Headache Evaluation at Altitude Trial (HEAT)","volume":"21","author":"Gertsch","year":"2010","journal-title":"Wilderness Environ Med"},{"key":"10.1016\/j.annemergmed.2011.10.015_bib13","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.wem.2010.10.009","article-title":"Spironolactone does not prevent acute mountain sickness: a prospective, double-blind, randomized, placebo-controlled trial by SPACE Trial Group (Spironolactone and Acetazolamide Trial in the Prevention of Acute Mountain Sickness Group)","volume":"22","author":"Basnyat","year":"2011","journal-title":"Wilderness Environ Med"},{"key":"10.1016\/j.annemergmed.2011.10.015_bib14","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1136\/jnnp.2007.124727","article-title":"Gabapentin for prevention of hypobaric hypoxia-induced headache: randomized double-blind clinical trial","volume":"79","author":"Jafarian","year":"2008","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.annemergmed.2011.10.015_bib15","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1002\/ana.21162","article-title":"Sumatriptan for prevention of acute mountain sickness: randomized clinical trial","volume":"62","author":"Jafarian","year":"2007","journal-title":"Ann Neurol"},{"key":"10.1016\/j.annemergmed.2011.10.015_bib16","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1089\/ham.2006.7.17","article-title":"Acetazolamide 125 mg BD is not significantly different from 375 mg BD in the prevention of acute mountain sickness: the Prophylactic Acetazolamide Dosage Comparison for Efficacy (PACE) trial","volume":"7","author":"Basnyat","year":"2006","journal-title":"High Alt Med Biol"},{"key":"10.1016\/j.annemergmed.2011.10.015_bib17","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1136\/bmj.38043.501690.7C","article-title":"Randomised, double blind, placebo controlled comparison of Ginkgo biloba and acetazolamide for prevention of acute mountain sickness among Himalayan trekkers: the Prevention of High Altitude Illness Trial (PHAIT)","volume":"328","author":"Gertsch","year":"2004","journal-title":"BMJ"},{"key":"10.1016\/j.annemergmed.2011.10.015_bib18","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1093\/qjmed\/hcp026","article-title":"Oral antioxidant supplementation does not prevent acute mountain sickness: double blind, randomized placebo-controlled trial","volume":"102","author":"Baillie","year":"2009","journal-title":"QJM"},{"key":"10.1016\/j.annemergmed.2011.10.015_bib19","first-page":"1","article-title":"Altitude sickness","volume":"3","author":"Murdoch","year":"2010","journal-title":"Clin Evid"},{"key":"10.1016\/j.annemergmed.2011.10.015_bib20","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1089\/ham.2008.1029","article-title":"Prophylactic low-dose acetazolamide reduces the incidence and severity of acute mountain sickness","volume":"9","author":"van Patot","year":"2008","journal-title":"High Alt Med Biol"},{"key":"10.1016\/j.annemergmed.2011.10.015_bib21","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1001\/archinte.165.3.296","article-title":"Ginkgo biloba and acetazolamide prophylaxis for acute mountain sickness: a randomized, placebo-controlled trial","volume":"165","author":"Chow","year":"2005","journal-title":"Arch Intern Med"}],"container-title":["Annals of Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196064411017008?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196064411017008?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,20]],"date-time":"2019-06-20T12:47:55Z","timestamp":1561034875000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0196064411017008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4]]},"references-count":20,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,4]]}},"alternative-id":["S0196064411017008"],"URL":"https:\/\/doi.org\/10.1016\/j.annemergmed.2011.10.015","relation":{},"ISSN":["0196-0644"],"issn-type":[{"value":"0196-0644","type":"print"}],"subject":[],"published":{"date-parts":[[2012,4]]}}}